Real-world use of complement inhibitors for haemolytic uraemic syndrome: an analysis of the European Rare Kidney Disease Registry cohort.
Vujović A, Sellier-Leclerc AL, Mancuso MC, Boyer O, Awan A, Gargiulo A, Loos S, Fila M, Jankauskiene A, Ariceta G, Kanzelmeyer N, Vidal E, Van Dyck M, Levart TK, Šimánková N, Decramer S, Hofstetter J, Vivarelli M, Sciascia S, van de Kar NCAJ, Schaefer F; ERKNet TMA Working Group.
Vujović A, et al.
EClinicalMedicine. 2025 Mar 27;82:103159. doi: 10.1016/j.eclinm.2025.103159. eCollection 2025 Apr.
EClinicalMedicine. 2025.
PMID: 40224677
Free PMC article.